Autor:
Warimwe, G.M.
Gesharisha, J.
Carr, B.V.
Otieno, S.
Otingah, K.
Wright, D.
Charleston, B.
Okoth, Edward A.
Elena, L.G.
Lorenzo, G.
Ayman, E.B.
Alharbi, N.K.
Al-Dubaib, M.A.
Brun, A.
Gilbert, S.C.
Nene, Vishvanath
Hill, A.V.S.
Rift Valley Fever virus (RVFV) causes recurrent outbreaks of acute life-threatening human and livestock illness in Africa and the Arabian Peninsula. No licensed vaccines are currently available for humans and those widely used in livestock have major safety concerns. A ‘One Health’ vaccine develo...
Enlace original:
https://cgspace.cgiar.org/handle/10568/71057
Warimwe, G.M.
,
Gesharisha, J.
,
Carr, B.V.
,
Otieno, S.
,
Otingah, K.
,
Wright, D.
,
Charleston, B.
,
Okoth, Edward A.
,
Elena, L.G.
,
Lorenzo, G.
,
Ayman, E.B.
,
Alharbi, N.K.
,
Al-Dubaib, M.A.
,
Brun, A.
,
Gilbert, S.C.
,
Nene, Vishvanath
,
Hill, A.V.S.
,
[Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever]
,
Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever
